[INGR] Ingredion Incorporated Thesis 2026: Texture Healthful Solutions Drive Specialty Ingredient Margin Mix Shift

Key Takeaways

• INGR FY2025 revenue ~$7.30-7.80B (+0-5% YoY) with adj. EPS ~$11.00-12.50 reflecting continued ~$2.60-2.90B aggregate Texture & Healthful Solutions + ~$3.20-3.60B aggregate Food & Industrial Ingredients North America + ~$1.40-1.70B aggregate Food & Industrial Ingredients LATAM revenue mix under continued President + CEO James Zallie since 2018 (~7-year tenure as Ingredion CEO; selected post-2018 succession from Ilene Gordon retirement after ~9-year tenure 2009-2018; selected primary internal promotion + selected primary architect of post-2018 strategic reset toward Texture & Healthful Solutions specialty ingredient mix shift + selected various aggregate post-2024-2025 portfolio optimization + cost discipline).
• Texture & Healthful Solutions Specialty Ingredient Pipeline (~$2.60-2.90B Revenue): ~$2.60-2.90B aggregate Texture & Healthful Solutions segment revenue (~35-38% revenue mix; ~highest-margin segment ~16-20% aggregate operating margin); selected primary specialty texturizers (selected primary modified + functional starches + hydrocolloids + selected various aggregate clean-label + non-GMO + organic texturizers) + selected various aggregate plant-based protein (selected primary pea protein + selected various aggregate ~$0+ aggregate plant-based protein revenue + selected various aggregate post-2020 PureCircle stevia/sugar reduction acquisition + selected various aggregate post-2020 Verdient Foods + Amyris plant protein JV considerations) + selected various aggregate sugar reduction (selected primary stevia + allulose + selected various aggregate ~$0+ aggregate sugar reduction revenue) + selected various aggregate sweetener nutrition + selected various aggregate ~$0+ aggregate fiber + prebiotics + selected various aggregate post-2024-2025 specialty ingredient mix shift toward Texture & Healthful Solutions (~targeting ~40%+ aggregate specialty revenue mix by ~2027-2028).
• Food & Industrial Ingredients North America + LATAM Core Pipeline (~$4.60-5.30B Revenue): ~$3.20-3.60B aggregate Food & Industrial Ingredients North America revenue + ~$1.40-1.70B aggregate Food & Industrial Ingredients LATAM revenue (aggregate ~62-65% revenue mix); selected primary Food & Industrial Ingredients North America (selected primary corn/grain-based starches + sweeteners — high fructose corn syrup (HFCS) + glucose syrup + dextrose + maltodextrin + selected various aggregate industrial starches — paper + corrugating + textile + selected various aggregate ~$3.20-3.60B aggregate FII-NA revenue + selected various aggregate ~8-12% aggregate FII-NA operating margin) + selected various aggregate Food & Industrial Ingredients LATAM (selected primary Brazil + Mexico + Andean + selected various aggregate corn/grain-based starches + sweeteners + selected various aggregate ~$1.40-1.70B aggregate FII-LATAM revenue + selected various aggregate ~10-15% aggregate FII-LATAM operating margin) + selected various aggregate ~corn cost net (gross profit vs corn cost spread) + selected various aggregate post-2024-2025 Food & Industrial Ingredients pricing + corn cost net margin dynamics.
• Capital position + balance sheet: ~$3.10 aggregate annual dividend (~25-30% aggregate payout ratio; ~2.0-3.0% aggregate dividend yield; selected ~15+ year aggregate consecutive dividend increase track record); ~$100-500M aggregate FY2025 buybacks; aggregate capital return ~$300-700M FY2025; net leverage ~1.5-2.5x Net Debt/EBITDA; investment-grade BBB/Baa2 credit rating; ~64-66M aggregate diluted shares.
• FY2026 thesis catalysts: Texture & Healthful Solutions Specialty Ingredient pipeline (~$2.60-2.90B + ~highest-margin segment ~16-20% operating margin + specialty texturizers + plant-based protein + sugar reduction + clean-label + ~targeting ~40%+ specialty revenue mix by 2027-2028) + Food & Industrial Ingredients North America + LATAM Core pipeline ($4.60-5.30B + corn/grain-based starches + sweeteners + industrial starches + ~corn cost net margin dynamics) + ~$300-700M aggregate FY2025 capital return + ~15+ year consecutive dividend increase track + James Zallie specialty ingredient mix shift + cost discipline execution.

Company Background

Ingredion Incorporated (NYSE: INGR) is a US global ingredient solutions company, founded 1906 as Corn Products Refining Company in New York (~119-year heritage; selected primary post-1906 founding focus on corn/grain wet milling + starches + sweeteners + selected post-1997 NYSE listing as Corn Products International + selected post-2010 Ingredion name change post-National Starch acquisition + selected post-2010-2025 specialty ingredient mix shift toward Texture & Healthful Solutions). Selected post-1997 NYSE listing; selected post-1997-2025 selected various aggregate ~$5B+ aggregate cumulative M&A platform (selected various aggregate National Starch 2010 + Penford 2014 + Sun Flour Industry + TIC Gums 2016 + Kerr Concentrates + Western Polymer + PureCircle 2020 + KaTech + selected various aggregate); selected post-2018 James Zallie CEO appointment (selected post-2018 succession from Ilene Gordon retirement after ~9-year tenure 2009-2018; selected post-2018 internal promotion); selected post-2018-2025 selected various aggregate Texture & Healthful Solutions specialty ingredient mix shift + portfolio optimization + cost discipline; HQ Westchester Illinois; ~12,000-13,000 employees globally.

INGR operates 3 primary segments: Texture & Healthful Solutions (~35-38% revenue mix; ~$2.60-2.90B; specialty texturizers + plant-based protein + sugar reduction + sweetener nutrition; ~highest-margin segment ~16-20% operating margin) + Food & Industrial Ingredients North America (~43-46% revenue mix; ~$3.20-3.60B; corn/grain-based starches + sweeteners — HFCS + glucose syrup + dextrose + maltodextrin + industrial starches; ~8-12% operating margin) + Food & Industrial Ingredients LATAM (~18-22% revenue mix; ~$1.40-1.70B; Brazil + Mexico + Andean corn/grain-based starches + sweeteners; ~10-15% operating margin). Geographic mix: North America ~55-60% + Latin America ~20-25% + EMEA + Asia Pacific ~15-25%.

Capital position: ~$3.10 aggregate annual dividend (~25-30% aggregate payout ratio; ~2.0-3.0% aggregate dividend yield; selected ~15+ year aggregate consecutive dividend increase track record); ~$100-500M aggregate FY2025 buybacks; aggregate capital return ~$300-700M FY2025; net leverage ~1.5-2.5x Net Debt/EBITDA; investment-grade BBB/Baa2 credit rating; ~64-66M aggregate diluted shares.

Texture & Healthful Solutions Specialty Ingredient Pipeline (~$2.60-2.90B Revenue)

The Texture & Healthful Solutions Specialty Ingredient pipeline is INGR's foundation thesis: ~$2.60-2.90B aggregate Texture & Healthful Solutions segment revenue (~35-38% revenue mix; ~highest-margin segment ~16-20% aggregate operating margin); selected primary specialty texturizers (selected primary modified + functional starches + hydrocolloids + selected various aggregate clean-label + non-GMO + organic texturizers) + selected various aggregate plant-based protein (selected primary pea protein + selected various aggregate ~$0+ aggregate plant-based protein revenue + selected various aggregate post-2020 PureCircle stevia/sugar reduction acquisition) + selected various aggregate sugar reduction (selected primary stevia + allulose + selected various aggregate ~$0+ aggregate sugar reduction revenue) + selected various aggregate sweetener nutrition + selected various aggregate ~$0+ aggregate fiber + prebiotics + selected various aggregate post-2024-2025 specialty ingredient mix shift toward Texture & Healthful Solutions (~targeting ~40%+ aggregate specialty revenue mix by ~2027-2028).

FY2025 Texture & Healthful Solutions Specialty Ingredient dynamics ($2.60-2.90B aggregate revenue): selected continued post-2024 ~+2-7% aggregate Texture & Healthful Solutions segment revenue growth (selected primary specialty texturizers demand + selected various aggregate clean-label + non-GMO + organic texturizer demand + selected various aggregate plant-based protein + sugar reduction demand + selected various aggregate ~16-20% aggregate operating margin + selected various aggregate Food & Beverage customer reformulation + selected various aggregate ~specialty ingredient pricing) + ~$2.60-2.90B aggregate Texture & Healthful Solutions segment revenue + selected various aggregate ~$0.45-0.55B aggregate Texture & Healthful Solutions operating income (~highest-margin segment). Selected post-2024 ~$6.50-7.50 incremental annual EPS contribution as Texture & Healthful Solutions Specialty Ingredient pipeline drives incremental high-margin specialty revenue.

FY2026 catalyst: continued Texture & Healthful Solutions Specialty Ingredient pipeline + ~$6.50-7.50 incremental annual EPS contribution under continued James Zallie leadership (~7-year tenure). Selected aggregate ~$2.70-3.05B aggregate FY2026 Texture & Healthful Solutions segment revenue + selected various ~+3-7% aggregate growth + selected various aggregate ~16-22% aggregate operating margin (improvement; specialty mix shift + cost discipline) + selected various aggregate specialty texturizers + plant-based protein + sugar reduction + clean-label demand + selected various aggregate Food & Beverage customer reformulation + selected various aggregate ~specialty ingredient pricing + selected various aggregate ~targeting ~40%+ aggregate specialty revenue mix by ~2027-2028. Risks: Cargill (private; #1 global agribusiness + ingredients) + Archer-Daniels-Midland (ADM, ~$25-35B Mcap; agribusiness + ingredients — Nutrition segment) + Tate & Lyle (UK; LON TATE; specialty food ingredients — sweeteners + texturizers + fibers) + Kerry Group (Ireland; ISE/LSE KYG/KRZ; food ingredients + flavors) + International Flavors & Fragrances (IFF, ~$20-25B; flavors + ingredients) + Givaudan (Switzerland; SIX GIVN; flavors + ingredients) + Roquette (private; French starch + protein) + Beneo/Südzucker (German starch + protein) + selected various aggregate global ingredient solutions + specialty texturizer + plant-based protein + sugar reduction competitive considerations + Food & Beverage customer reformulation cycle considerations + clean-label demand cycle considerations + selected various aggregate plant-based protein demand cycle considerations + selected various aggregate specialty ingredient pricing considerations.

Food & Industrial Ingredients North America + LATAM Core Pipeline (~$4.60-5.30B Revenue)

The Food & Industrial Ingredients North America + LATAM Core pipeline is INGR's primary core thesis: ~$3.20-3.60B aggregate Food & Industrial Ingredients North America revenue + ~$1.40-1.70B aggregate Food & Industrial Ingredients LATAM revenue (aggregate ~62-65% revenue mix); selected primary Food & Industrial Ingredients North America (selected primary corn/grain-based starches + sweeteners — high fructose corn syrup (HFCS) + glucose syrup + dextrose + maltodextrin + selected various aggregate industrial starches — paper + corrugating + textile + selected various aggregate ~$3.20-3.60B aggregate FII-NA revenue + selected various aggregate ~8-12% aggregate FII-NA operating margin) + selected various aggregate Food & Industrial Ingredients LATAM (selected primary Brazil + Mexico + Andean + selected various aggregate corn/grain-based starches + sweeteners + selected various aggregate ~$1.40-1.70B aggregate FII-LATAM revenue + selected various aggregate ~10-15% aggregate FII-LATAM operating margin) + selected various aggregate ~corn cost net (gross profit vs corn cost spread) + selected various aggregate post-2024-2025 Food & Industrial Ingredients pricing + corn cost net margin dynamics.

FY2025 Food & Industrial Ingredients North America + LATAM Core dynamics: selected primary ~$3.20-3.60B aggregate FII-NA revenue + selected various aggregate ~8-12% aggregate FII-NA operating margin + selected various aggregate corn/grain-based starches + sweeteners — HFCS + glucose syrup + dextrose + maltodextrin + industrial starches + selected various aggregate ~$1.40-1.70B aggregate FII-LATAM revenue + selected various aggregate ~10-15% aggregate FII-LATAM operating margin + selected various aggregate Brazil + Mexico + Andean corn/grain-based starches + sweeteners + selected various aggregate ~corn cost net (gross profit vs corn cost spread) + selected various aggregate post-2024-2025 Food & Industrial Ingredients pricing + corn cost net margin dynamics (selected primary post-2023-2024 corn cost normalization + selected various aggregate pricing pass-through). Selected post-2024 ~$5.00-6.00 incremental annual EPS contribution as Food & Industrial Ingredients North America + LATAM Core pipeline drives incremental core margin.

FY2026 catalyst: continued Food & Industrial Ingredients North America + LATAM Core pipeline + ~$5.00-6.00 incremental EPS contribution. Selected aggregate ~$3.25-3.65B aggregate FY2026 FII-NA revenue + selected various aggregate ~8-13% aggregate FII-NA operating margin + selected various aggregate ~$1.45-1.75B aggregate FY2026 FII-LATAM revenue + selected various aggregate ~10-16% aggregate FII-LATAM operating margin + selected various aggregate corn/grain-based starches + sweeteners — HFCS + glucose syrup + dextrose + maltodextrin + industrial starches + selected various aggregate Brazil + Mexico + Andean corn/grain-based starches + sweeteners + selected various aggregate ~corn cost net margin dynamics + selected various aggregate post-2024-2025 Food & Industrial Ingredients pricing + cost discipline. Risks: Cargill + Archer-Daniels-Midland (ADM) + Tate & Lyle + Roquette + Grain Processing Corporation (private; corn starch + sweeteners) + Tereos (France; starch + sweeteners) + Cosan/Raízen (Brazil; ethanol + sugar) + selected various aggregate North America + LATAM corn/grain-based starch + sweetener competitive considerations + corn cost cycle considerations (corn cost net margin sensitivity) + HFCS demand cycle considerations (selected primary sugar substitution + consumer sweetener preferences) + industrial starch demand cycle considerations (paper + corrugating + textile) + selected various aggregate Brazil + Mexico + Andean economic + currency cycle considerations + selected various aggregate ethanol economics considerations (corn dry milling vs wet milling) + selected various aggregate post-2024-2025 Food & Industrial Ingredients pricing considerations.

Capital Position + Balance Sheet

Capital position + balance sheet: ~$3.10 aggregate annual dividend (~25-30% aggregate payout ratio; ~2.0-3.0% aggregate dividend yield; selected ~15+ year aggregate consecutive dividend increase track record) + ~$100-500M aggregate FY2025 buybacks + aggregate capital return ~$300-700M FY2025 + net leverage ~1.5-2.5x Net Debt/EBITDA + investment-grade BBB/Baa2 credit rating + ~64-66M aggregate diluted shares + weighted average debt maturity ~5-7 years.

FY2026 catalyst: continued ~$310-720M aggregate annual capital return + selected continued ~2.0-3.0% aggregate dividend yield + selected continued ~$3.10-3.30 aggregate annual dividend (post-FY2025 ~16+ year continuous consecutive dividend increase track record) + selected continued ~1.5-2.5x net leverage + selected various aggregate ~$100-500M aggregate annual buybacks + selected continued investment-grade BBB/Baa2 credit rating. Selected ~25-30% aggregate payout ratio + selected investment-grade BBB/Baa2 credit rating + selected ~1.5-2.5x net leverage discipline + selected various aggregate Texture & Healthful Solutions + Food & Industrial Ingredients free cash flow generation support continued dividend + buyback + specialty ingredient mix shift + tuck-in M&A capacity.

Key Core Metrics

• FY2025 revenue ~$7.30-7.80B (+0-5% YoY) vs $7.43B FY2024; adj. EPS ~$11.00-12.50
• 3 segments: Texture & Healthful Solutions ~35-38% ($2.60-2.90B; ~highest-margin ~16-20% operating margin) + Food & Industrial Ingredients North America ~43-46% ($3.20-3.60B; ~8-12% operating margin) + Food & Industrial Ingredients LATAM ~18-22% ($1.40-1.70B; ~10-15% operating margin)
• Geographic mix: North America ~55-60% + Latin America ~20-25% + EMEA + Asia Pacific ~15-25%
• Texture & Healthful Solutions: specialty texturizers (modified + functional starches + hydrocolloids + clean-label + non-GMO + organic) + plant-based protein (pea protein) + sugar reduction (stevia + allulose; PureCircle) + sweetener nutrition + fiber + prebiotics
• Specialty revenue mix target: ~40%+ aggregate by ~2027-2028
• Food & Industrial Ingredients North America: corn/grain-based starches + sweeteners (HFCS + glucose syrup + dextrose + maltodextrin) + industrial starches (paper + corrugating + textile)
• Food & Industrial Ingredients LATAM: Brazil + Mexico + Andean corn/grain-based starches + sweeteners
• Corn cost net (gross profit vs corn cost spread): key margin driver
• Aggregate adj. EBITDA: ~$1.1-1.3B FY2025
• Net leverage ~1.5-2.5x Net Debt/EBITDA
• ~64-66M aggregate diluted shares; ~$300-700M total capital return FY2025
• Dividend ~$3.10 annual (~25-30% payout; ~2.0-3.0% yield; ~15+ year consecutive dividend increase track record)
• ~$100-500M aggregate FY2025 buybacks
• Investment-grade BBB/Baa2 credit rating
• ~12,000-13,000 employees globally
• James Zallie CEO since 2018 (~7-year tenure; internal promotion from Ilene Gordon retirement)
• HQ Westchester Illinois; founded 1906

Market Evaluation

INGR FY2026 market evaluation: at ~$130-180 share price + ~64-66M aggregate diluted shares = ~$8.5-12B market cap; ~$3.10 aggregate annual dividend + ~2.0-3.0% aggregate dividend yield. Selected primary INGR peers: Cargill (private; #1 global agribusiness + ingredients) + Archer-Daniels-Midland (ADM, ~$25-35B Mcap; agribusiness + ingredients — Nutrition segment) + Tate & Lyle (UK; LON TATE; specialty food ingredients — sweeteners + texturizers + fibers) + Kerry Group (Ireland; ISE/LSE KYG/KRZ; food ingredients + flavors) + International Flavors & Fragrances (IFF, ~$20-25B; flavors + ingredients) + Givaudan (Switzerland; SIX GIVN; flavors + ingredients) + Sensient Technologies (SXT, ~$3-5B; colors + flavors + ingredients) + Balchem (BCPC, ~$4-6B; specialty ingredients) + Darling Ingredients (DAR, ~$5-8B; rendered ingredients + bioenergy) + Bunge Global (BG, ~$14-16B; agribusiness + food processing) + selected various aggregate global ingredient solutions + specialty food ingredient + agribusiness companies. Selected INGR ~10-15x P/E (global ingredient solutions with Texture & Healthful Solutions specialty ingredient mix shift + Food & Industrial Ingredients North America + LATAM core + ~15+ year consecutive dividend increase track record + ~corn cost net margin discipline) + selected ~7-10x EV/EBITDA + selected ~2.0-3.0% dividend yield + selected aggregate ~$7.40-7.95B aggregate FY2026 revenue + selected aggregate ~$11.50-13.00 aggregate FY2026 EPS + selected aggregate ~$310-720M aggregate FY2026 capital return + selected aggregate Texture & Healthful Solutions Specialty Ingredient + Food & Industrial Ingredients North America + LATAM Core pipeline. FY2026 base case: ~$7.40-7.95B aggregate revenue + ~$11.50-13.00 adj. EPS + ~$310-720M aggregate capital return. Bull case: Texture & Healthful Solutions Specialty Ingredient pipeline acceleration (specialty texturizers + plant-based protein + sugar reduction + clean-label demand + ~16-22% operating margin + ~targeting ~40%+ specialty revenue mix by ~2027-2028 + Food & Beverage customer reformulation acceleration) + Food & Industrial Ingredients North America + LATAM Core pipeline acceleration (corn cost net margin expansion + pricing pass-through + Brazil + Mexico + Andean growth + cost discipline) drives ~$7.70-8.30B aggregate revenue + ~$13.00-14.50 EPS. Bear case: Cargill + ADM + Tate & Lyle + Kerry Group + IFF + Givaudan + Roquette + Grain Processing + Tereos competitive intensification + Food & Beverage customer reformulation cycle considerations + clean-label demand cycle considerations + plant-based protein demand cycle considerations + corn cost cycle considerations (corn cost net margin sensitivity) + HFCS demand cycle considerations (sugar substitution + consumer sweetener preferences) + industrial starch demand cycle considerations (paper + corrugating + textile) + Brazil + Mexico + Andean economic + currency cycle considerations + ethanol economics considerations + specialty ingredient pricing considerations + post-2018 James Zallie CEO succession planning considerations (~7-year tenure) drives ~$7.10-7.40B revenue + ~$10.00-11.50 EPS. The thesis depends on Texture & Healthful Solutions Specialty Ingredient + Food & Industrial Ingredients North America + LATAM Core + ~highest-margin Texture & Healthful Solutions ~16-20% operating margin + ~targeting ~40%+ specialty revenue mix by ~2027-2028 + ~corn cost net margin discipline + ~15+ year consecutive dividend increase track + James Zallie specialty ingredient mix shift + cost discipline execution.